Atlas Trials

Single Center Registration Study on HER2 Expression and Clinical Pathological Characteristics in Prostate Cancer

Clinical trial NCT06146114 · UNKNOWN

Trial details

NCT number
NCT06146114
Sponsor
Qilu Hospital of Shandong University
Status
UNKNOWN
Study type
OBSERVATIONAL
HER2 Expression and Clinical Pathological Characteristics in Prostate Cancer
Start date
2023-07-01
Primary completion
2024-05-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.